UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048036
Receipt number R000054747
Scientific Title Prospective Registry Observational Study of Carbon Ion Radiation Therapy in Mucosal Malignant Melanoma of the Head and Neck
Date of disclosure of the study information 2022/06/13
Last modified on 2023/02/17 16:32:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Registry Observational Study of Carbon Ion Radiation Therapy in Mucosal Malignant Melanoma of the Head and Neck

Acronym

Prospective Registry Observational Study of Carbon Ion Radiation Therapy in Mucosal Malignant Melanoma of the Head and Neck

Scientific Title

Prospective Registry Observational Study of Carbon Ion Radiation Therapy in Mucosal Malignant Melanoma of the Head and Neck

Scientific Title:Acronym

Prospective Registry Observational Study of Carbon Ion Radiation Therapy in Mucosal Malignant Melanoma of the Head and Neck

Region

Japan


Condition

Condition

Mucosal Malignant Melanoma of the Head and Neck

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the efficacy of an acceptable treatment approach that allows the use of immune checkpoint inhibitors after carbon ion radiotherapy for mucosal malignant melanoma of the head and neck

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The overall survival rate will be evaluated between two groups, one with and the other without immune checkpoint inhibitors administered within the usual care after carbon ion radiotherapy.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with histologically proven mucosal malignant melanoma of the head and neck region.
2) Patients with N0M0 (TNM classification, 8th edition).
3) Patients with measurable lesions.
4) Patients who are scheduled to receive heavy particle radiotherapy.
5) Patients who are 16 years of age or older.
6) Patients whose Performance Status (PS) is 0-2.
7) Patients who have been informed of the name and condition of their disease and have the capacity to consent.
(For minors, the consent of a legal guardian is required.)

Key exclusion criteria

1) Patients with a history of radiation therapy to the area to be treated.
2) Patients with active and refractory infection at the irradiated site.
3) Patients with serious complications (uncontrolled diabetes mellitus, myocardial infarction requiring emergency treatment, unstable angina, uncontrolled arrhythmia, bleeding tendency due to untreated bleeding disorder, collagen disease requiring steroid administration, etc.)
4) Patients with active multiple cancers (simultaneous multiple cancers and iatrogenic multiple cancers with a disease-free interval of 5 years or less). However, lesions equivalent to intraepithelial or intramucosal carcinoma that are considered curable by local treatment are not included in the active overlapping cancers.
5) Other patients who are deemed medically, psychologically, or due to other factors to be inappropriate by the physician in charge.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Ohno

Organization

Gunma University Graduate School of Medicine

Division name

Department of Radiation Oncology

Zip code

3718511

Address

3-39-22 Showa-machi, Maebashi, Gunma

TEL

027-220-8383

Email

tohno@gunma-u.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Musha

Organization

Gunma University

Division name

Heavy Ion Medical Center

Zip code

3718511

Address

3-39-22 Showa-machi, Maebashi, Gunma

TEL

027-220-8378

Homepage URL


Email

musha@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University Hospital Clinical Research Review Board

Address

3-39-15 Showa-machi, Maebashi, Gunma

Tel

027-220-8740

Email

gunmaciru-office@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 06 Month 07 Day

Date of IRB

2022 Year 05 Month 19 Day

Anticipated trial start date

2022 Year 06 Month 13 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2022 Year 06 Month 12 Day

Last modified on

2023 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054747